EMPAGEN-M 12.5/1000MG TABLET

Empagen-M 12.5/1000mg Tablet is a combination medication that includes two active ingredients: EMPAGLIFLOZIN+METFORMIN. It is commonly prescribed for the management of type 2 diabetes mellitus.

Active Ingredients:

1. Empagliflozin (12.5mg):
   • Empagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor. It works by reducing the reabsorption of glucose by the kidneys, leading to increased glucose excretion in the urine.
2. Metformin (1000mg):
   • Metformin is a biguanide antidiabetic medication that helps lower blood glucose levels by reducing glucose production in the liver and improving insulin sensitivity in the body.

Uses:

1. Type 2 Diabetes Management: Empagen-M 12.5/1000mg Tablet is used to manage type 2 diabetes mellitus by improving glycemic control.

Dosage and Administration:

• The dosage is determined by the healthcare provider based on the patient’s individual response, medical history, and specific needs.
• Tablets are typically taken orally, with or without food, as directed by the prescribing physician.

Side Effects:

Common side effects may include:

• Genital infections (more common with SGLT2 inhibitors)
• Gastrointestinal discomfort
• Hypoglycemia (low blood sugar) when combined with other antidiabetic medications

Serious side effects are rare but may include lactic acidosis (more common with metformin). Consult a healthcare professional if any severe or persistent side effects occur.

When Not to Use:

1. Allergies: Avoid Empagen-M 12.5/1000mg Tablet if allergic to Empagliflozin, Metformin, or any other components.

Precautions and Warnings:

1. Renal Function: Caution is advised in individuals with impaired renal function, as both Empagliflozin and Metformin may affect kidney function.
2. Lactic Acidosis Risk: Metformin carries a risk of lactic acidosis, especially in individuals with kidney or liver impairment.
3. Pregnancy and Breastfeeding: Consult with a healthcare professional before using Empagen-M during pregnancy or while breastfeeding.

Conclusion:

Empagen-M 12.5/1000mg Tablet, combining Empagliflozin and Metformin, is an effective medication for managing type 2 diabetes mellitus. It should be used under the guidance of a healthcare professional, and any concerns or side effects should be promptly discussed with the prescribing physician. Regular monitoring of blood glucose levels and adherence to the prescribed dosage are crucial for optimal diabetes management.